Ex-Peloton Therapeutics CEO launches biotech startup with $60M

Two years after Peloton Therapeutics was acquired by Merck & Co. Inc. (NYSE: MRK), Peloton CEO John A. Josey is leading a new startup based on technology out of the Howard Hughes Medical Institute and the University of Texas Southwestern Medical Center.